Regional Monitoring EECA
by ECUO PLWH
Regional Monitoring EECA
Showing 1-9 of 9 items.
| # | Country | Source of financing | Manufacturer | Tradename | INN | Form | Price per unit ($) | Units in purchase | Units in package | Price per package ($) | Packages in purchase | Price per purchase ($) | Distributor | Year | Purchase date | Delivery date | Registered | In the list of main (vital) medications | WHO prequalification |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Republic of Armenia | Global Fund | Cipla Ltd | Lamivudine+Nevirapine+Zidovudine - FDC | 150mg+200mg+300mg tab | 0.139 | 15840 | 60 | 8.34 | 264 | 2201.76 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 2 | Republic of Tajikistan | Global Fund | Cipla Ltd | Lamivudine+Nevirapine+Zidovudine - FDC | 30mg+50mg+60mg tab | 0.0617 | 110160 | 60 | 3.7 | 1836 | 6793.2 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 3 | Republic of Moldova | Government | Ranbaxy Laboratories Limited | Avocomb N | Lamivudine+Nevirapine+Zidovudine - FDC | 150mg+200mg+300mg tab | 0.1913 | 148680 | 30 | 5.74 | 4956 | 28447.44 | Dita Estfarm SRL | 2015 | Not specified | Not specified | Not specified | ||
| 4 | Republic of Tajikistan | Global Fund | Cipla Ltd | Lamivudine+Nevirapine+Zidovudine - FDC | 150mg+200mg+300mg tab | 0.1567 | 60 | 60 | 9.4 | 1 | 9.4 | 2015 | Not specified | Not specified | Not specified | ||||
| 5 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Lamivudine+Nevirapine+Zidovudine - FDC | 150mg+200mg+300mg tab | 0.1543 | 19260 | 60 | 9.26 | 321 | 2972.46 | 2015 | Not specified | Yes | Not specified | ||||
| 6 | Republic of Moldova | Global Fund | Ranbaxy Laboratories Limited | Lamivudine+Nevirapine+Zidovudine - FDC | 150mg+200mg+300mg tab | 0.1543 | 19260 | 60 | 9.26 | 321 | 2972.46 | IDA Foundation | Not specified | Not specified | Not specified | ||||
| 7 | Republic of Tajikistan | Global Fund | MYLAN LABORATORIES LTD | Lamivudine+Nevirapine+Zidovudine - FDC | 150mg+200mg+300mg tab | 0.135 | 252000 | 60 | 8.1 | 4200 | 34020 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 8 | Republic of Tajikistan | Global Fund | Matrix | Lamivudine+Nevirapine+Zidovudine - FDC | 30mg+50mg+60mg tab | 0.0608 | 60 | 60 | 3.65 | 1 | 3.65 | 2015 | Not specified | Not specified | Not specified | ||||
| 9 | Russian Federation | Government | Hetero labs Ltd. | Zidolam-N | Lamivudine+Nevirapine+Zidovudine - FDC | 300mg+200mg+150mg tab | 0.9542 | 141060 | 60 | 57.25 | 2351 | 134594.75 | 2015 | Not specified | Not specified | Not specified |